Letters to the Editor

This letter is associated with the following article:
Glaxo's guinea pigs The pharma giant is accused of putting pregnant women at risk in unethical drug trials.
  • Why don't they ever define "defects?"

    Why is it that whenever I read an article (such as this one) that mentions "birth defects" as a result of some drug or other factor, it never specifies what KIND of defects? Are we talking about a relatively mild condition that can easily be remedied by modern medicine, or a truly life-altering tragedy? In other words, what kind of cost-benefit analysis is being applied in terms of danger to the mother if she DOESN'T take the substance, vs. potential and degree of danger to the baby if she DOES?

Most Active Stories

Read More

Letters Help

Daily Delivery

Salon headlines in your mailbox